Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: mattstat who wrote (10415)	6/7/2018 6:15:53 PM
From: BoredMember	Respond to of 12871

Yes, another flip flopper blaming Dr. Anil Diwan for their own inability to do due diligence. Nothing was changed in the deal, not a single letter. But What was fine before is bad now. The deal hasn’t changed at all, but now you’re upset. If you weren’t comfortable with Dr. Anil Diwan getting fully reimbursed for his expenses in helping Nanoviricides move forward, plus a little profit for himself of a mere thirty percent, then maybe you shouldn’t have invested. Hind sight is 20/20. Save your bashing for the angry board please.